Efficacy of the bisphosphonate APD∗∗(Note on the nomenclature: Traditional abbreviations for identifying compounds have been used in the text. According to IUPAC: Nomenclature of Organic Chemistry, Sections A-H (Pergamon Press, Oxford, 1979), the new abbreviations are as follows: APD = AHP1BP: 3-amino-1-hydroxypropylidene-1,1-bisphosphonate EHDP = HEBP: 1-hydroxyethylidene-1,1-bisphosphonate Cl2MDP = Cl2MBP: Dichloromethylenebisphosphonate. in the control of Paget's bone disease
- 1 January 1985
- Vol. 6 (6), 429-432
- https://doi.org/10.1016/8756-3282(85)90219-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.BMJ, 1984
- Review of Fracture Experience During Treatment of Paget??s Disease of Bone with Etidronate Disodium (EHDP)Published by Wolters Kluwer Health ,1983
- Regulation of calcium absorption by 1,25,dihydroxy-vitamin D—Studies of the effects of a bisphosphonate treatmentCalcified Tissue International, 1982
- Clinical and biological effects of low doses of (3 amino‐1 hydroxypropylidene)‐1,1‐bisphosphonate (APD) in Paget's disease of boneEuropean Journal of Clinical Investigation, 1982
- Paget's disease of bone.BMJ, 1982
- Apd in paget's disease of bone role of the mononuclear phagocyte system?Arthritis & Rheumatism, 1980
- BISPHOSPHONATES AND PAGET'S DISEASEThe Lancet, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (E.H.D.P.) IN PAGET'S DISEASEThe Lancet, 1975